Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Real-Time MRI-Guided Prostate Interventions. Cancers Masoom, S. N., Sundaram, K. M., Ghanouni, P., Futterer, J., Oto, A., Ayyagari, R., Sprenkle, P., Weinreb, J., Arora, S. 2022; 14 (8)

Abstract

Prostate cancer (PCa) is the second most common cause of cancer death in males. Targeting MRI-visible lesions has led to an overall increase in the detection of clinically significant PCa compared to the prior practice of random ultrasound-guided biopsy of the prostate. Additionally, advances in MRI-guided minimally invasive focal treatments are providing new options for patients with PCa. This review summarizes the currently utilized real-time MRI-guided interventions for PCa diagnosis and treatment.

View details for DOI 10.3390/cancers14081860

View details for PubMedID 35454773